Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis

被引:34
|
作者
Saresella, M. [2 ]
Rolland, A. [3 ]
Marventano, I. [2 ]
Cavarretta, R. [4 ]
Caputo, D. [4 ]
Marche, P. [3 ]
Perron, H. [5 ]
Clerici, M. [1 ,2 ]
机构
[1] Univ Milan, Dept Biomed Sci & Technol, Chair Immunol, I-20090 Milan, Italy
[2] Don C Gnocchi ONLUS Fdn IRCCS, Lab Mol Med & Biotechnol, I-20148 Milan, Italy
[3] CEA, INSERUM, U548, Lab Immunochim, F-38054 Grenoble, France
[4] Don C Gnocchi ONLUS Fdn, IRCCS, Multiple Sclerosis Unit, I-20148 Milan, Italy
[5] GeNeuro, Geneva, Switzerland
关键词
cytokines; ENV-SU protein; human endogenous retroviruses (HERV); immunology; multiple sclerosis; T lymphocytes; ENVELOPE PROTEIN; MSRV; EXPRESSION; LYMPHOCYTES;
D O I
10.1177/1352458508100840
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Human endogenous retroviruses are suggested to play a pathogenic role in multiple sclerosis (MS); one of such retroviruses, the MS-associated retroviral agent (MSRV) has repeatedly been isolated in MS patients. Objective and methods We analyzed cytokine profiles in MSRV envelope protein (MSRV ENV-SU)stimulated peripheral blood mononuclear cells of 30 relapsing-remitting MS patients with either acute (AMS) (n = 13) or stable (SMS) (n = 17) disease. Results suggest that MSRV ENV-SU induces the production of inflammatory cytokines, including tumor necrosis factor-alpha (P < 0.05) and interferon-gamma (P < 0.004) in AMS patients and of interleukin-10 (P < 0.05), an inflammation-dampening cytokine, in SMS individuals. Conclusions These data strengthen the hypothesis indicating that MSRV could be involved in the pathogenesis of MS. Multiple Sclerosis 2009; 15: 443-447. http://msj.sagepub.com
引用
收藏
页码:443 / 447
页数:5
相关论文
共 50 条
  • [11] Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis
    Nocentini, U
    Pasqualetti, P
    Bonavita, S
    Buccafusca, M
    De Caro, MF
    Farina, D
    Girlanda, P
    Le Pira, F
    Lugaresi, A
    Quattrone, A
    Reggio, A
    Salemi, G
    Savettieri, G
    Tedeschi, G
    Trojano, M
    Valentino, P
    Caltagirone, C
    MULTIPLE SCLEROSIS, 2006, 12 (01): : 77 - 87
  • [12] Multiple sclerosis-associated retrovirus, Epstein-Barr virus, and vitamin D status in patients with relapsing remitting multiple sclerosis
    Mostafa, Aliehossadat
    Jalilvand, Somayeh
    Shoja, Zabihollah
    Nejati, Ahmad
    Shahmahmoodi, Shohreh
    Sahraian, Mohammad Ali
    Marashi, Sayed Mahdi
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (07) : 1309 - 1313
  • [13] Vestibular rehabilitation in patients with relapsing-remitting multiple sclerosis
    Pavan, Karina
    Marangoni, Bruna E. M.
    Schmidt, Kizi B.
    Cobe, Femanda A.
    Matuti, Gabriela S.
    Nishino, Lucia K.
    Thomaz, Rodrigo B.
    Mendes, Maria Fernanda
    Lianza, Sergio
    Tilbery, Charles Peter
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (2A) : 332 - 335
  • [14] Altered Serum Cytokine Profiles in Relapse Phase of Relapsing-Remitting Multiple Sclerosis
    Peiravian, Forooz
    Rajaian, Hamid
    Samiei, Afshin
    Gholijani, Nasser
    Gharesi-Fard, Behrouz
    Mokaram, Pooneh
    Rahimi-Jaberi, Abbas
    Sarvestani, Eskandar Kamali
    IRANIAN JOURNAL OF IMMUNOLOGY, 2016, 13 (03) : 186 - 196
  • [15] Screening for dysphagia in patients with relapsing-remitting multiple sclerosis
    Kocica, Jan
    Lasotova, Nadezda
    Kolcava, Jan
    Svobodova, Monika
    Hladikova, Magdalena
    Stourac, Pavel
    Bednarik, Josef
    Vlckova, Eva
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 83
  • [16] Neurovascular coupling in patients with relapsing-remitting multiple sclerosis
    Uzuner, Gulnur Tekgol
    Uzuner, Nevzat
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2016, 146 : 24 - 28
  • [17] Low and dysregulated production of follistatin in immune cells of relapsing-remitting multiple sclerosis patients
    Urshansky, Nataly
    Mausner-Fainberg, Karin
    Auriel, Eitan
    Regev, Keren
    Karni, Arnon
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 238 (1-2) : 96 - 103
  • [18] A simple mathematical model for relapsing-remitting multiple sclerosis (RRMS)
    Elettreby, M. F.
    Ahmed, E.
    MEDICAL HYPOTHESES, 2020, 135
  • [19] Development of laquinimod for relapsing-remitting multiple sclerosis
    Jeffery, Douglas R.
    FUTURE NEUROLOGY, 2008, 3 (06) : 641 - 648
  • [20] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
    Menge, Til
    Dubey, Divyanshu
    Warnke, Clemens
    Hartung, Hans-Peter
    Stuve, Olaf
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139